HC Wainwright Has Strong Estimate for AKRO FY2028 Earnings
Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) – Analysts at HC Wainwright increased their FY2028 earnings per share estimates for Akero Therapeutics in a research report issued to clients and investors on Monday, November 11th. HC Wainwright analyst E. Arce now expects that the company will post earnings per share of $1.66 for the year, […]
13 Nov 12:40 · The Markets Daily